Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Temozolomide and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Trial of Bevacizumab in Myelodysplastic Syndromes (Int-1, Int-2 and High Risk According to International Prognostic Scoring System (IPSS)) With Excess of Marrow Blasts
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Prevention of Vision Loss in Patients With Age-Related Macular Degeneration (AMD) by Intravitreal Injection of Bevacizumab and Ranibizumab
- Status
- UNKNOWN
- Phase
- PHASE3
XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Intraocular Bevacizumab (Avastin) for Rubeosis Iridis
- Status
- COMPLETED
- Phase
- PHASE4
Intravitreal Bevacizumab for Choridal Neovascularization Secondary to Age-Related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE4
Bevacizumab With or Without Sunitinib in Sunitinib-Refractory Renal Cell Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of Bevacizumab and Erlotinib in Patients With Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Enzastaurin and Bevacizumab in Treating Patients With Locally Advanced or Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment
- Status
- COMPLETED
- Phase
- PHASE1
Preoperative Dose-dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab in Operable Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab Versus Ranibizumab for Diabetic Retinopathy
- Status
- COMPLETED
- Phase
- PHASE3
Bevacizumab + Endocrine Treatment vs Endocrine Treatment as First Line in Postmenopausal Women
- Status
- COMPLETED
- Phase
- PHASE3
Bevacizumab in Treating Patients Who Have Undergone First-Line Therapy for Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE3